TWO SIGMA INVESTMENTS, LP

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1179392 NEW YORK, NY

Position in VYGR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,376,447

+$1,501,185 QoQ

Shares Held

615,660

+176.4% QoQ

Ownership

1.02%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,513,200,662 across 316 Biotechnology names. VYGR ranks #150 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,992,577	$659,283,951
2	REGN	Regeneron Pharmaceuticals, Inc.	812,236	$627,566,023
3	MRNA	Moderna, Inc.	9,086,404	$461,589,323
4	IONS	Ionis Pharmaceuticals Inc	5,857,629	$439,849,361
5	BBIO	BridgeBio Pharma, Inc.	3,120,631	$231,738,058
6	VRTX	Vertex Pharmaceuticals Inc / Ma	378,146	$168,857,314
7	RVMD	Revolution Medicines, Inc.	1,558,807	$151,593,980
8	VKTX	Viking Therapeutics, Inc.	4,432,142	$144,221,900

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,376,447	615,660	+176.4%	Shares	Sole	2026-05-15
2025-12-31	$875,262	222,713	+58.3%	Shares	Sole	2026-02-17
2025-09-30	$657,139	140,715	+536.4%	Shares	Sole	2025-11-14
2024-03-31	$205,862	22,112	+0.1%	Shares	Sole	2024-05-15
2023-12-31	$186,524	22,100	-34.2%	Shares	Sole	2024-02-14
2023-09-30	$260,400	33,600	-41.5%	Shares	Sole	2023-11-14
2023-06-30	$657,172	57,395	+120.8%	Shares	Sole	2023-08-14
2023-03-31	$200,460	26,000	-22.2%	Shares	Sole	2023-05-15
2022-06-30	$197,553	33,427	-65.3%	Shares	Sole	2022-08-15
2022-03-31	$735,002	96,457	+616.7%	Shares	Sole	2022-05-16
2021-06-30	$55,585	13,459	-95.9%	Shares	Sole	2021-08-16
2021-03-31	$1,540,141	326,994	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.